Re: Additional Reports Of Exempt Distribution.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

fuzzyjr

Rank: Vice President [?]

Points: 5268 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Reports Of Exempt Distribution.

in response to

Additional Reports Of Exempt Distribution.

KOO-KOO2

posted on Jun 05, 2024 04:27PM

Is zenith subject to blackout periods/similiar rules etc as the TSX?

e.g would they/zenith be allowed to do these placements at whatever price they want or even legally if they are in the middle of working on a deal of any kind that may greatly benifit the people who are taking part in them?

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply